Clinical Trial Update: Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial [Phase 4]

View source ↗

Summary

The PRISMA ESCUDDO Phase 4 trial evaluates a single-dose HPV vaccination strategy to prevent cervical cancer in young adult women in Costa Rica and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• HPV vaccine (single-dose regimen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Status: ACTIVE_NOT_RECRUITING